Skip to content

Gulf War Illness: Evaluation of an Innovative Detoxification Program

Pilot Study of Application of the Hubbard Detoxification Program to Veterans With Gulf War Illness

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01672710
Enrollment
32
Registered
2012-08-27
Start date
2010-04-30
Completion date
2015-12-31
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gulf War Illness

Keywords

Hubbard detoxification, Exercise, Sauna therapy, Niacin, Gulf War illness

Brief summary

Gulf War illness is found in about one fourth of veterans of the 1990-1991 Gulf War and is characterized by persistent memory and concentration problems, headaches, fatigue and muscle and joint pain. It is not known what causes the illness, but exposure to chemicals is suspected. The Hubbard detoxification program consists of exercise and sauna therapy together with administration of several dietary supplements, particularly crystalline niacin used at increasing concentrations over a period of about four weeks. The investigators hypothesize that this program will reduce symptoms, as tested by administration of cognitive and quality of life tests and serum clinical chemistry tests.

Detailed description

This will be a pilot randomized controlled trial of feasibility, safety and changes in fatigue and pain symptoms, measured quality of life, mental health status, and neuro-cognitive functioning of a group of GWVs after a 4 to 6 week sauna detoxification regimen as compared to control. For control subjects we will also have a group of GWVs receiving usual care who are randomly assigned to a waitlist and who will start the intervention after a four to six week delay. The waitlist group will also take part in the baseline tests a second time just prior to their treatment 4 to 6 weeks later and a 7-day post-treatment battery of tests the same as described for the treatment group. Finally, there will be a 3-month follow-up with both the groups. The Severna Park Health and Wellness Center (SPHWC) is a commercial center that offers the Hubbard detoxification program. The investigators will contract with SPHWC to provide the program to the subjects of this study and to provide office space for the Study Coordinator, so that all components of this project except the initial Physician evaluation and blood sample acquisition can be done at the Center, not just the detoxification. Study Variables: The investigators will examine feasibility of the research design, and safety of the regimen and estimate changes in: * Quality of life as measured by the Veterans Short Form (SF36-V). The SF36-V also includes physical (PCS) and mental (MCS) component summary scores. * Case status for GWI will be assessed utilizing the Kansas criteria. * Symptoms of fatigue and pain in GWI will be measured wit, the Multidimensional Fatigue Inventory, and the short-form McGill Pain-2 Questionnaire. * Cognitive function will be measured with a battery of neurocognitive tests. These will include visual motor, memory and executive functioning as measured by the Trailmaking test, Grooved Pegboard, Wechsler Memory Abbreviated test, and the Stroop color word test. To account for potential confounding in neurocognitive testing, mental health status will be evaluated using the Symptom Checklist 90 revised and the State Trait Anxiety Inventory. * Physical health status will be assessed via standard medical examination and laboratory analyses of serum metabolic panel, lipid profile and hormones. Sampling Method: This will be a convenience sample and will consist of Gulf War Veterans who meet the Kansas case definition for Gulf War illness and reside in the Washington/Baltimore area or can travel to and reside in the area for several weeks. The individuals who show interest in this study, who meet eligibility criteria and subsequently agree to participate will be selected to enroll in the study. Randomization: Volunteers will be randomly assigned to a group when they enroll. One group will be the immediate experimental intervention group and one group will be the wait-list control group. Random assignment will be achieved by use of sequentially numbered, opaque, sealed envelopes. Both will undergo the detoxification protocol, but the control group will be tested twice prior to treatment.

Interventions

DRUGplain crystalline niacin, exercise, sauna

A four to six week regimen consisting of daily, supervised, mild-moderate exercise as tolerated for 20 minutes, supervised, intermittent Finnish saunas (at about 140'F) sauna time with breaks and showers, gradually increased as tolerated to approximately 4 hours, dietary supplements including immediate release niacin in gradually increasing doses from 100 mg to a maximum of 5000 mg per day, salt and water, other vitamins, minerals and oils per Hubbard protocol.

Sponsors

United States Department of Defense
CollaboratorFED
The Sage Colleges
CollaboratorOTHER
Women's College Hospital
CollaboratorOTHER
Severna Park Health and Wellness Center
CollaboratorUNKNOWN
University at Albany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Pilot

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Any veteran of the 1990-1991 Gulf War who meets the Kansas Gulf War Illness case definition.

Exclusion criteria

* Veterans who meet the inclusion criteria but have been diagnosed by a physician with (1) chronic conditions (eg., cancer, heart disease, diabetes, liver disease, multiple sclerosis, etc.) that are not associated with Gulf War service but can produce diverse symptoms similar to Gulf War Illness; (2) conditions that might interfere with respondents' ability to report symptoms (eg., psychiatric conditions or history of hospitalization for depression, alcohol or drug dependence; (3) pregnancy or unwillingness to use contraception.

Design outcomes

Primary

MeasureTime frameDescription
Short Form-36 for Veterans Quality of Life Physical Component Summary Scoresbaseline, 5 weeksQualify of life will be determined per Short Form-36 for veterans quality of life Physical component (PCS) summary scales, range from 0 to 100 with 100 being better; 50 is expected population average. immediate intervention and waitlist groups changes compared from baseline and adjusted mean differences at end of 5 weeks.

Secondary

MeasureTime frameDescription
Fatigue Severitybaseline, 5 weeksMultidimensional fatigue inventory. change in Self reported fatigue severity. Measures 5 dimensions of fatigue: general, physical, mental, reduced motivation and reduced activity. Scores 4-20 in each dimension, higher score worse fatigue.

Countries

United States

Participant flow

Participants by arm

ArmCount
Niacin, Exercise, Sauna,
plain crystalline niacin, exercise, sauna: A four to six week regimen consisting of daily, supervised, mild-moderate exercise as tolerated for 20 minutes, supervised, intermittent Finnish saunas (at about 140'F) sauna time with breaks and showers, gradually increased as tolerated to approximately 4 hours, dietary supplements including immediate release niacin in gradually increasing doses from 100 mg to a maximum of 5000 mg per day, salt and water, other vitamins, minerals and oils per Hubbard protocol.
22
no Intervention
treatment as usual for 4 weeks
10
Total32

Withdrawals & dropouts

PeriodReasonFG000FG001
3 Month Follow upfollow up due after termination date41
3 Month Follow upLost to Follow-up23
Waitlist Assessed After Sauna RegimenWithdrawal by Subject01

Baseline characteristics

CharacteristicNiacin, Exercise, Sauna,no InterventionTotal
Age, Continuous51.7 years
STANDARD_DEVIATION 7.9
50.2 years
STANDARD_DEVIATION 5.5
51.2 years
STANDARD_DEVIATION 7.2
Sex: Female, Male
Female
7 Participants3 Participants10 Participants
Sex: Female, Male
Male
15 Participants7 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 220 / 10
other
Total, other adverse events
3 / 220 / 10
serious
Total, serious adverse events
0 / 220 / 10

Outcome results

Primary

Short Form-36 for Veterans Quality of Life Physical Component Summary Scores

Qualify of life will be determined per Short Form-36 for veterans quality of life Physical component (PCS) summary scales, range from 0 to 100 with 100 being better; 50 is expected population average. immediate intervention and waitlist groups changes compared from baseline and adjusted mean differences at end of 5 weeks.

Time frame: baseline, 5 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Niacin, Exercise, Sauna,Short Form-36 for Veterans Quality of Life Physical Component Summary Scoresbaseline PCS score30.3 score on a scaleStandard Deviation 8.9
Niacin, Exercise, Sauna,Short Form-36 for Veterans Quality of Life Physical Component Summary Scores5 week PCS scores38.2 score on a scaleStandard Deviation 10.3
no InterventionShort Form-36 for Veterans Quality of Life Physical Component Summary Scoresbaseline PCS score36.7 score on a scaleStandard Deviation 10.5
no InterventionShort Form-36 for Veterans Quality of Life Physical Component Summary Scores5 week PCS scores35.7 score on a scaleStandard Deviation 12.1
p-value: <0.0595% CI: [-0.3, 14.2]ANCOVA
Secondary

Fatigue Severity

Multidimensional fatigue inventory. change in Self reported fatigue severity. Measures 5 dimensions of fatigue: general, physical, mental, reduced motivation and reduced activity. Scores 4-20 in each dimension, higher score worse fatigue.

Time frame: baseline, 5 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Niacin, Exercise, Sauna,Fatigue SeverityBaseline fatigue score17.4 score on a scaleStandard Deviation 2.6
Niacin, Exercise, Sauna,Fatigue Severity5 week fatigue score12.8 score on a scaleStandard Deviation 4.8
no InterventionFatigue SeverityBaseline fatigue score15.3 score on a scaleStandard Deviation 5.3
no InterventionFatigue Severity5 week fatigue score15.7 score on a scaleStandard Deviation 3.6

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026